XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 2,389,583 $ 66,446
General and administrative 839,627 516,716
Total operating expenses 3,229,210 583,162
Operating loss (3,229,210) (583,162)
Other income (expense):    
Change in fair value of derivative liability   (26,500)
Interest income (expense), net 197 10,634
Grant income 29,340 157,438
Total other income (expense) 29,537 141,572
Loss before income taxes (3,199,673) (441,590)
Income tax expense (benefit) 0 0
Net loss $ (3,199,673) $ (441,590)
Basic and diluted loss per common share $ (0.46) $ (0.10)
Weighted average number of common shares outstanding, basic and diluted 6,920,622 4,599,469